Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells

Cancer Investigation

Volumn 30, Issue 1, 2012, Pages 38-47

  Goncalves, Kevin ^a   Sullivan, Katie ^a   Phelan, Shelley ^a  

^a Fairfield University College of Arts and Sciences   (United States)

Author keywords

Breast cancers; Gene expression; Molecular biology

Indexed keywords

HYDROGEN PEROXIDE; MESSENGER RNA; PEROXIREDOXIN 1; PEROXIREDOXIN 6; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL COUNT; CELL STRAIN MCF 7; CELL VIABILITY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; FEMALE; HUMANS; HYDROGEN PEROXIDE; PEROXIREDOXIN VI; PEROXIREDOXINS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84855862391     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.629382     Document Type: Article

References (40)

1. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine, 3rd edition. New York: Oxford University Press, 1999.
2. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1-11. (Pubitemid 46115897)
3. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem-Biol Interact 2006;160:1-40. (Pubitemid 43227479)
4. Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002;7(3):123-130. (Pubitemid 34700435)
5. Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem 2002;383(3-4):347-364. (Pubitemid 34506276)
6. Wood ZA, Schroïder E, Harris JR, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003;28(1):32-40.
7. Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 2005;7(5):768-777. (Pubitemid 40563217)
8. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Rad Biol Med 2005;38:1543-1552. (Pubitemid 40726061)
9. Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 2001;21(3B):2085-2090.
10. Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 2002;196(3):316-323. (Pubitemid 34189421)
11. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL, Soini Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res 2003;15(9):3418-3424. (Pubitemid 37082738)
12. Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M. Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 2004;111(4):514-521. (Pubitemid 39045317)
13. Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Enhanced expression of peroxiredoxin I and VI correlates with development recurrence and progression of human bladder cancer. J Urolol 2006;175(4):1512-1516.
14. Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 2007;9(6):R76.
15. Butterfield LH, Merino A, Golub SH, Shau H. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid Redox Signal 1999;1(4):385-402. (Pubitemid 129628306)
16. Kinnula VL, Paakko P, Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 2004;569(1-3):1-6. (Pubitemid 38844583)
17. Neumann CA, Fang Q. Are peroxiredoxins tumor suppressors? Curr Opin Pharm 2007;7(4):375-380.
18. LiDQ, Wang L, Fei F,Hou YF, Luo JM,Wei-Chen, Zeng R, Wu J, Lu JS,Di GH, Ou ZL, XiaQC, Shen ZZ, Shao ZM. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 2006;6(11):3352-3368. (Pubitemid 43886152)
19. Bae J, Ahn S, Han W, Noh D. Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines. J Cell Biochem 2007;101:1038-1045.
20. Chahed K, Kabbage M, Hamrita B, Guillier CL, Trimeche M, Remadi S, Ehret-Sabatier L, Chouchane L. Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis. Clin Chim Acta 2008;388(1-2):106-114. (Pubitemid 350266579)
21. Ishii T, Yamada M, Sato H, Matsue M, Taketani S, Nakayama K, Sugita Y, Bannai S. Cloning and characterization of a 23- kDa stress-induced mouse peritoneal macrophage protein. J Biol Chem 1993;268(25):18633-18636. (Pubitemid 23273802)
22. Wen ST, Van Etten RA. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev 1997;11:2456-2467. (Pubitemid 27438828)
23. Berggren MI, Husbeck B, Samulitis B, Baker AF, Gallegos A, PowisG.Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch Biochem Biophys 2001;392(1):103-109. (Pubitemid 32725020)
24. Zhou Y, ZhangW, Easton R, Ray JW, Lampe P, Jiang Z, Brunkan AL, Goate A, Johnson EM, Wu JY. Presenilin-1 protects against neuronal apoptosis caused by its interacting protein PAG. Neurobiol Dis 2002;9(2):126-138. (Pubitemid 34261209)
25. Mu ZM, Yin XY, Prochownik EV. Pag, a putative tumor suppressor, interacts with the Myc box II domain of c-Myc and selectively alters its biological function and target gene expression. J Biol Chem 2002;277:43175-43184. (Pubitemid 35285703)
26. Egler RA, Fernandes E, Rothermund K, Sereika S, de Souza-Pinto N, Jaruga P, Dizdaroglu M, Prochownik EV. Regulation of eactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 2005;24(54):8038-8050. (Pubitemid 41746747)
27. Conway JP, Kinter M. Dual role of peroxiredoxin I in macrophage-derived foamcells. J Biol Chem 2006;281(38):27991-28001. (Pubitemid 44414512)
28. Chang R, Wang E. Mouse translation elongation factor eEF1A- 2 interacts with Prdx-I to protect cells against apoptotic death 278.
29. Manevich Y, Fisher AB. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Rad Biol Med 2005;38:1422-1432. (Pubitemid 40693827)
30. Manevich Y, Sweitzer T, Pak JH, Feinstein SI, Muzykantov V, Fisher AB. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci 2002;99:11599-11604. (Pubitemid 34994445)
31. Phelan SA, Wang X, Wallbrandt P, Forsman-Semb K, Paigen B. Overexpression of peroxiredoxin VI reduces H2O2 but does not prevent diet-induced atherosclerosis. Free Rad Biol Med 2003;35(9):1110-1120. (Pubitemid 37315703)
32. Wang Y, Manevich Y, Feinstein SI, Fisher AB. Adenovirusmediated transfer of the 1-cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Amer J Physiol Lung Cell Mol Physiol 2004;286(6):L1188-L1193. (Pubitemid 38656654)
33. Wang Y, Phelan SA, Manevich Y, Feinstein SI, Fisher AB. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Amer J Respir Cell Mol Biol 2006;34(4):481-486.
34. Wang Y, Feinstein S, Fisher A. Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from H2O2-induced oxidative stress. J Cell Biochem 2008;104(4):1274-1285. (Pubitemid 351961700)
35. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002;277:49927-49934. (Pubitemid 36014442)
36. Wang X, Phelan SA, Forsman-Semb K, Couturier EF, Brown A, Lerner CP, Paigen B. Mice with targeted mutation of peroxiredoxint develop normally but are susceptible to oxidative stress. J Biol Chem 2003;278(27):25179-25190. (Pubitemid 37548683)
37. Kumin A, Huber C, Rulicke T, Wolf E, Werner S. Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis epithelial and mesenchymal. Cell Biol 2006;169:1194-1205. (Pubitemid 351194356)
38. Wang Y, Feinstein SI, Manevich Y, Ho YS, Fisher AB. Peroxiredoxin 6 gene-targeted mice show increased lung injury with paraquat induced oxidative stress. Antioxid Redox Signal 2006;8:229-237. (Pubitemid 43324549)
39. Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Meth Enzym 2001;25:402-408. (Pubitemid 34164012)
40. Neumann CA, Krause DS, Carman CV. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defense and tumour suppression. Nature 2003;424:561-565. (Pubitemid 36975778)